In this episode, Thomas Averre, Managing Director of Tarleton Communications, discusses the critical communication strategies biotech startups must adopt to successfully navigate the fundraising landscape, particularly in overcoming the 'valley of death' between early-stage funding and Series A. He emphasizes the importance of early engagement with investors, crafting compelling narratives, and maintaining a balance between ambitious goals and realistic expectations. The conversation also covers common mistakes startups make in their presentations, the significance of a well-structured communication plan during due diligence, and the role of media in attracting investor interest.

📌 Here's what we cover in this episode:

00:00 Introduction to Tarleton Communications
02:25 Understanding the Valley of Death in Biotech
06:31 Crafting effective messaging for startups
10:10 Creating a compelling narrative for investors
13:32 Common mistakes in early-stage biotech communication
19:07 Choosing the right communication channels
22:43 Long-term strategies for building investor relationships
27:48 Key advice for biotech founders
29:37 Recommended resources for effective communication

📖 Books recommended by Thomas:

• The Choice Factory: How 25 Behavioural Biases Influence the Products We Decide to Buy, by Richard Shotton
• Ogilvy on Advertising, by David Ogilvy
• Media in Focus: Marketing Effectiveness in the Digital Era, by Les Binet and Peter Field

🤝 To connect with Thomas:

• LinkedIn (https://www.linkedin.com/in/thomas-averre/)
• Tarleton's website (https://www.tarletoncomms.com/)

🎤 To connect with Joachim Eeckhout, host of the podcast:

• LinkedIn (https://www.linkedin.com/in/joachimeeckhout/)
• Contact form (https://www.thesciencemarketer.com/contact/)

✅ Subscribe to The Science Marketer newsletter: https://www.thesciencemarketer.com/